docetaxel anhydrous has been researched along with Atypical Hemolytic-Uremic Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boito, R; Bova, F; Colombo, AF; Greco, S; LucĂ , R; Rizzuto, G; Sellaro, A | 1 |
1 other study(ies) available for docetaxel anhydrous and Atypical Hemolytic-Uremic Syndrome
Article | Year |
---|---|
[Atypical Hemolitic Uremic Syndrome after administration of Docetaxel].
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Atypical Hemolytic Uremic Syndrome; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Fluorouracil; Humans; Lymph Node Excision; Male; Middle Aged; Penile Neoplasms; Plasma; Postoperative Complications; Renal Dialysis; Taxoids | 2018 |